Literature DB >> 16783410

Novel therapeutic strategies for reducing arterial stiffness.

Carmel M McEniery1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16783410      PMCID： PMC1751920          DOI： 10.1038/sj.bjp.0706805

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  25 in total

1.  An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

Authors:  M Asif; J Egan; S Vasan; G N Jyothirmayi; M R Masurekar; S Lopez; C Williams; R L Torres; D Wagle; P Ulrich; A Cerami; M Brines; T J Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

Review 3.  Arterial stiffness, hypertension and diabetes mellitus.

Authors:  J R Cockcroft; D J Webb; I B Wilkinson
Journal:  J Hum Hypertens       Date:  2000-06       Impact factor: 3.012

4.  Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Authors:  D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

5.  Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.

Authors:  S Laurent; P Boutouyrie; R Asmar; I Gautier; B Laloux; L Guize; P Ducimetiere; A Benetos
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

6.  Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats.

Authors:  C Cantini; P Kieffer; B Corman; P Limiñana; J Atkinson; I Lartaud-Idjouadiene
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

7.  A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.

Authors:  P V Vaitkevicius; M Lane; H Spurgeon; D K Ingram; G S Roth; J J Egan; S Vasan; D R Wagle; P Ulrich; M Brines; J P Wuerth; A Cerami; E G Lakatta
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

8.  Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

Authors:  S S Franklin; M J Jacobs; N D Wong; G J L'Italien; P Lapuerta
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

9.  Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.

Authors:  Vincent Chan; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

10.  Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.

Authors:  J A Staessen; J Gasowski; J G Wang; L Thijs; E Den Hond; J P Boissel; J Coope; T Ekbom; F Gueyffier; L Liu; K Kerlikowske; S Pocock; R H Fagard
Journal:  Lancet       Date:  2000-03-11       Impact factor: 79.321
View more
  2 in total

1.  Arterial stiffness and the response to carotid sinus massage in older adults.

Authors:  Kenneth M Madden; Chris Lockhart; Karim Khan
Journal:  Aging Clin Exp Res       Date:  2010-02-05       Impact factor: 3.636

2.  Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia.

Authors:  Kenneth M Madden; Chris Lockhart; Darcye Cuff; Tiffany F Potter; Graydon S Meneilly
Journal:  Diabetes Care       Date:  2009-06-09       Impact factor: 17.152
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.